Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study-Reference-Cited by-同舟云学术

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

Published:2012-05-05 Issue:1 Volume:72 Page:64-71
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Kavanaugh Arthur,Fleischmann Roy M,Emery Paul,Kupper Hartmut,Redden Laura,Guerette Benoit,Santra Sourav,Smolen Josef S

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

2. Real-world effectiveness of a single conventional disease-modifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study;Journal of Rheumatic Diseases;2024-01-29

3. Initial Treatment with Biological Therapy in Rheumatoid Arthritis;Journal of Clinical Medicine;2023-12-21

4. Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity;Arthritis Research & Therapy;2023-10-20

5. Cost–utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands;Annals of the Rheumatic Diseases;2023-07-09